Hookipa Pharma (NASDAQ:HOOK – Get Free Report)‘s stock had its “outperform” rating reiterated by equities researchers at Royal Bank of Canada in a note issued to investors on Monday, Benzinga reports. They currently have a $5.00 price objective on the stock. Separately, HC Wainwright reissued a “buy” rating and set a $6.50 price target on […]
Shares of Hookipa Pharma Inc (NASDAQ:HOOK – Get Free Report) were down 16.5% during mid-day trading on Monday . The stock traded as low as $0.71 and last traded at $0.72. Approximately 9,262,100 shares were traded during trading, an increase of 749% from the average daily volume of 1,090,797 shares. The stock had previously closed […]
Royal Bank of Canada reiterated their outperform rating on shares of Hookipa Pharma (NASDAQ:HOOK – Free Report) in a research report released on Wednesday morning, Benzinga reports. Royal Bank of Canada currently has a $7.00 target price on the stock. Several other equities research analysts have also issued reports on HOOK. HC Wainwright lowered their […]
Truist Financial restated their buy rating on shares of Hookipa Pharma (NASDAQ:HOOK – Free Report) in a research note published on Wednesday, Benzinga reports. They currently have a $4.00 price target on the stock. Several other brokerages have also issued reports on HOOK. Royal Bank of Canada reissued an outperform rating and issued a $7.00 […]
Hookipa Pharma (NASDAQ:HOOK – Get Free Report) posted its quarterly earnings results on Thursday. The company reported ($0.22) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.21) by ($0.01), reports. The company had revenue of $2.68 million during the quarter, compared to the consensus estimate of $3.54 million. Hookipa Pharma had a […]